UZ Leuven

Leuven, Belgium

132 recruiting

Showing 120 of 313 trials

Recruiting
Phase 4

Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

Ischemic Stroke
Insel Gruppe AG, University Hospital Bern906 enrolled14 locationsNCT06571149
Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

Myotonic DystrophyDM1Steinert Disease+2 more
Dyne Therapeutics150 enrolled20 locationsNCT07486934
Recruiting
Phase 3

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Hypertension, Pulmonary
Actelion280 enrolled45 locationsNCT05179876
Recruiting
Phase 3

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast NeoplasmsNeoplasm Metastasis
Eli Lilly and Company800 enrolled346 locationsNCT07174336
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Systemic Sclerosis
Boehringer Ingelheim448 enrolledNCT07497087
Recruiting
Phase 3

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled341 locationsNCT07028853
Recruiting

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

Cardiovascular Diseases
Medtronic Cardiac Surgery5,000 enrolled14 locationsNCT04241328
Recruiting
Not Applicable

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

Diabetes (Insulin-requiring, Type 1 or Type 2)
Medtronic MiniMed, Inc.116 enrolled9 locationsNCT07227805
Recruiting
Phase 3

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Amyotrophic Lateral Sclerosis
Prilenia500 enrolled56 locationsNCT07322003
Recruiting
Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis
Boehringer Ingelheim1,755 enrolled470 locationsNCT06872892
Recruiting
Phase 2

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

Hyperkalemia
Vifor Pharma, Inc.32 enrolled37 locationsNCT05766839
Recruiting
Phase 3

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Dravet Syndrome
Longboard Pharmaceuticals160 enrolled102 locationsNCT06660394
Recruiting

LEOPARD Training and Validation Data Collection Study

Primary Biliary CholangitisPrimary Sclerosing CholangitisDecompensated Liver Cirrhosis+1 more
Assistance Publique - Hôpitaux de Paris4,500 enrolled53 locationsNCT06675604
Recruiting
Phase 1Phase 2

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

Ovarian Cancer
Tubulis GmbH72 enrolled5 locationsNCT07736937
Recruiting
Phase 2

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer+1 more
North Eastern German Society of Gynaecological Oncology640 enrolled50 locationsNCT05460000
Recruiting
Phase 2

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

Invasive Mould Infection
Elion Therapeutics, Inc.60 enrolled18 locationsNCT07215273
Recruiting
Phase 2

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

Rheumatoid Arthritis
Hoffmann-La Roche160 enrolled56 locationsNCT07137598
Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1149 locationsNCT07064473
Recruiting
Phase 2

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension PAH
Regeneron Pharmaceuticals99 enrolled24 locationsNCT07318597
Recruiting
Not Applicable

Performance After Cardiac Ablation in Endurance Athletes for Atrial Fibrillation

Atrial Fibrillation (AF)
University Hospital of Leuven Leuven100 enrolled5 locationsNCT07726056